• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

WHO to evaluate Ivermectin efficacy as treatment for Covid-19

Messages
157
Professor Paul Marik of Eastern Virginia Medical School and co-developer of the MATH+ Protocol, has revealed that the WHO has appointed Dr.Andrew Hill of Liverpool University to review the efficacy of Ivermectin against Covid-19.

Apparently, the WHO is encouraged by the results of the 11 RCT's using Ivermectin and is looking forward to reviewing the results of 3 more RCT's which will be published in January. Professor Marik says he hopes the WHO will then have enough evidence to make a judgement on Ivermectin. We can take a crumb of comfort from this action of the WHO, which has made many mistakes this year, but to its credit it did come out against Remdesivir despite its endorsement by NIH and big pharma. Even now the New England Journal of Medicine is publishing new studies into Remdesivir, no doubt paid for by big pharma.

Professor Marik's views on the WHO can be found at 46.08 mins into his presentation. His presentation talks about the anti-viral and anti-inflammatory properties of vitamin C and Ivermectin to a group of critical care specialists from India.

Plus In the USA the Senate Committee on Homeland Security has sent a letter to NIH asking for it review the data on Ivermectin's efficacy as a treatment for Covid-19 by December 23. Please see a link to the letter below. It will be interesting to see if NIH ignores or complies with this request.
https://www.hsgac.senate.gov/imo/media/doc/40-317_Comm. Homeland Security Gov. Affairs 12-10-2020.pdf


Latest News:
Please find below an interview with Dr.Andrew Hill of Liverpool University.
Dr.Hill's analysis is very favourable towards the use of Ivermectin to treat Covid-19 patients.
He found that Ivermectin treatment of Covid-19 patients was associated wth:
Faster time to viral clearance,
Shorter duration of hospitalisation
43% higher rates of clinical recovery
83% improval in survival rates

He is waiting for the results of 3 more RCT's in January before being in a position to make any recommendations to the WHO on Ivermectin use to treat Covid-19 patients. In his conlcusion regarding Ivermectin Dr. Hill says:
"if we see these same trends consistently across more studies then this is going to be a transformational treatment.''
His findings on Ivermectin can be found on the link below:
 
Last edited: